BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22560665)

  • 21. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.
    Scaini G; Morais MO; Galant LS; Vuolo F; Dall'Igna DM; Pasquali MA; Ramos VM; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Soriano FG; Dal-Pizzol F; Streck EL
    Mol Neurobiol; 2014 Oct; 50(2):358-67. PubMed ID: 24390570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memantine Improves Memory and Neurochemical Damage in a Model of Maple Syrup Urine Disease.
    Lemos IDS; Torres CA; Alano CG; Matiola RT; de Figueiredo Seldenreich R; Padilha APZ; De Pieri E; Effting PS; Machado-De-Ávila RA; Réus GZ; Leipnitz G; Streck EL
    Neurochem Res; 2024 Mar; 49(3):758-770. PubMed ID: 38104040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.
    Scaini G; Morais MO; Furlanetto CB; Kist LW; Pereira TC; Schuck PF; Ferreira GC; Pasquali MA; Gelain DP; Moreira JC; Bogo MR; Streck EL
    Neurochem Res; 2015 May; 40(5):885-93. PubMed ID: 25681161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.
    Scaini G; Mello-Santos LM; Furlanetto CB; Jeremias IC; Mina F; Schuck PF; Ferreira GC; Kist LW; Pereira TC; Bogo MR; Streck EL
    Mol Neurobiol; 2013 Dec; 48(3):581-9. PubMed ID: 23559405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of the
    Tsai HY; Wu SC; Li JC; Chen YM; Chan CC; Chen CH
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32680850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats.
    Bridi R; Latini A; Braum CA; Zorzi GK; Moacir W; Lissi E; Dutra-Filho CS
    Free Radic Res; 2005 Jan; 39(1):71-9. PubMed ID: 15875814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
    Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
    Mescka CP; de Moura Coelho D; Sitta A; Catarino F; Donida B; Rosa AP; Gonzalez EA; Pinheiro CV; Poletto F; Baldo G; Dutra-Filho CS; Vargas CR
    Metab Brain Dis; 2021 Jun; 36(5):1015-1027. PubMed ID: 33620579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
    Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
    Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters.
    Rabelo F; Lemos IDS; Dal Toé CP; Casagrande DD; Freitas MLS; Quadra MR; Lima IR; Generoso JS; Michels M; Silveira PCL; Pizzol FD; Streck EL
    Metab Brain Dis; 2023 Jun; 38(5):1573-1579. PubMed ID: 36897514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.
    Ribeiro CA; Sgaravatti AM; Rosa RB; Schuck PF; Grando V; Schmidt AL; Ferreira GC; Perry ML; Dutra-Filho CS; Wajner M
    Neurochem Res; 2008 Jan; 33(1):114-24. PubMed ID: 17680360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease.
    Wu JY; Kao HJ; Li SC; Stevens R; Hillman S; Millington D; Chen YT
    J Clin Invest; 2004 Feb; 113(3):434-40. PubMed ID: 14755340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.